These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11903234)

  • 1. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.
    Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD
    Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.
    Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E
    J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of MART-1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients.
    Enk CD; Lotem M; Gimon Z; Hochberg M
    Melanoma Res; 2004 Oct; 14(5):361-5. PubMed ID: 15457091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
    Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
    Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analyses of sentinel lymph nodes: an open question.
    Bonin S; Niccolini B; Calacione R; Gambardella B; Geatti O; Stanta G; Trevisan G
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):34-9. PubMed ID: 11952287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of melanoma mRNA markers in sentinel nodes: pre-clinical evaluation of a single-step real-time reverse transcriptase-polymerase chain reaction assay.
    Abrahamsen HN; Nexo E; Steiniche T; Hamilton-Dutoit SJ; Sorensen BS
    J Mol Diagn; 2004 Aug; 6(3):253-9. PubMed ID: 15269303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
    Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
    Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
    Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
    Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
    Lukowsky A; Bellmann B; Ringk A; Winter H; Audring H; Fenske S; Sterry W
    J Invest Dermatol; 1999 Oct; 113(4):554-9. PubMed ID: 10504440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
    Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
    Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.
    Shidham VB; Qi D; Rao RN; Acker SM; Chang CC; Kampalath B; Dawson G; Machhi JK; Komorowski RA
    BMC Cancer; 2003 May; 3():15. PubMed ID: 12735792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
    Blaheta HJ; Schittek B; Breuninger H; Garbe C
    Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
    Davids V; Kidson SH; Hanekom GS
    Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies.
    Gutzmer R; Kaspari M; Brodersen JP; Mommert S; Völker B; Kapp A; Werfel T; Kiehl P
    Histopathology; 2002 Dec; 41(6):510-8. PubMed ID: 12460203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
    Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
    Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR.
    Giese T; Engstner M; Mansmann U; Hartschuh W; Arden B
    J Invest Dermatol; 2005 Mar; 124(3):633-7. PubMed ID: 15737205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of sentinel lymph node status examined with conventional histology and molecular biology.
    Micciolo R; Boi S; Paoli L; Cristofolini P; Girlando S; Dalla Palma P; Cristofolini M
    Tumori; 2009; 95(3):298-302. PubMed ID: 19688967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.